Amagai, Yosuke <br/><br/>
Combination therapy of interleukin-2 and sorafenib improves survival benefits and prevents spontaneous pulmonary metastasis in murine renal cell carcinoma models.  [electronic resource] 

 -  Japanese journal of clinical oncology  Jun 2010 
 - 503-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1465-3621 
<br/><br/><label>Standard No.: </label>10.1093/jjco/hyp200  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzenesulfonates--administration & dosage<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Line, Tumor<br/>Female<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--drug therapy<br/>Lung Neoplasms--mortality<br/>Mice<br/>Mice, Inbred BALB C<br/>Nephrectomy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Pyridines--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Sorafenib<br/>Survival Rate